基于网络药理学及分子对接技术探讨血必净注射液治疗新型冠状病毒肺炎的潜在靶标及机制
周辉芳1, 王君平1, 苏利波2, 王燕3, 孙涛涛1, 杨新英3, 张聪悦3, 谢英2,*, 孙殿兴1,3,*

Exploring the potential targets and mechanisms of Xuebijing Injection for COVID-19 based on network pharmacology and molecular docking technology
ZHOU Hui-fang1, WANG Jun-ping1, SU Li-bo2, WANG Yan3, SUN Tao-tao1, YANG Xin-ying3, ZHANG Cong-yue3, XIE Ying2, SUN Dian-xing1,3
关键化合物槲皮素与核心蛋白IL1B分子对接